The portable machine can manufacture four drugs formulated as solutions or suspensions: Benadryl, lidocaine, Valium and Prozac. Using the machine, the researchers can produce about 1,000 doses of a given drug in 24 hours.
Four new plants in the United States, Ireland and Spain will increase the company’s capacity for plasma fractionation and purification of the resulting proteins.
University of Copenhagen researchers will conduct research into how powder materials and dry ingredients for pharmaceutical products can be can be manufactured in an optimal way and withstand long-distance shipment.
The report said that the turnaround in the U.S. market’s revenue potential is being driven by concerns over quality in some Asian markets and a marked shift in the drug development pipeline towards difficult to formulate drugs and biosimilars.
The FDA proposes a pathway for pharmaceutical companies seeking to modernize their manufacturing technology to improve drug quality.